Clinical Trials Directory

Trials / Completed

CompletedNCT05259670

Risk Factors for Recurrent Intussusception Successful Reduction in Pediatric Patients

Risk Factors for Recurrent Intussusception After Successful Reduction in Pediatric Patients in a Tertiary Care Hospital of Nepal: A Prospective-Study

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
Sanjeev Kharel · Academic / Other
Sex
All
Age
0 Years – 16 Years
Healthy volunteers
Not accepted

Summary

To determine risk factors associated with recurrent intussusception among pediatric patients who have undergone successful reduction at a tertiary care hospital.

Detailed description

This is the prospective observational study. In this study, 78 patients,age \<16 years with diagnosis of intussusception between June 2019 and April 2020 who had successful reduction with either hydrostatic reduction and/or operative reduction in Teaching Hospital were enrolled in the study. They were followed up to a period of 1 month for recurrence of intussusception. The recurrent cases were thus identified and various variables were compared between recurrent and non-recurrent cases by univariable and multivariable analysis. This prospective observational study was approved by the ethics committees of Institutional review board of Tribhuvan University, Institute of Medicine. A standard structured questionnaire was filled by interviewing the patient (if possible) and family members/relatives after taking informed written consent. The questionnaire documented the patient's age, sex, weight, duration of symptoms, presenting symptoms: abdominal pain, excessive cry, vomiting, lethargy, blood in stool, fever, palpable mass, constipation, diarrhoea ,location of mass, enlarged lymph nodes(LNs), blood counts and methods of reduction. Age of 2 years, weight of 12 kg and duration of symptoms of 48 hours was used to classify patients into two groups

Conditions

Timeline

Start date
2019-06-01
Primary completion
2020-04-01
Completion
2020-04-01
First posted
2022-02-28
Last updated
2022-02-28

Locations

2 sites across 1 country: Nepal

Source: ClinicalTrials.gov record NCT05259670. Inclusion in this directory is not an endorsement.